Aitiologic
PrivateLast Round
Seed
Sep 15, 2026
Total Funding Raised
$7.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Aitiologic operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Seed round in September 2026.
Aitiologic is a precision medicine company that develops tissue-resolved liquid biopsy solutions using its proprietary AI-powered aitios® platform to analyze cell-free DNA for early disease detection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aitiologic Comparables
Compare Aitiologic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EarlyDiagnostics | 78% | |
| Adela | 73% | |
| Natera, Inc. | 69% |
For institutional investors. Book with your work email.
Aitiologic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 15, 2026 | ||||
| Seed | Oct 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aitiologic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PUSH VC | Seed |
| Ananda Ventures | Seed |
| Heal Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 2, representing 22% of headcount.
- Sep 15, 2026
$7.4M round led by Heal Capital and Ananda Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 15, 2026
Aitiologic GmbH receives $7.42M Seed financing co-led by Heal Capital and Ananda Impact Ventures, with participation from PUSH VC and LANA Ventures, to advance its tissue-resolved liquid biopsy platform and preeclampsia lead program in Austria on Sep 15th '26.
For institutional investors. Book with your work email.
Aitiologic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aitiologic's valuation, stock price, and market status.
Is Aitiologic a public or private company?
Aitiologic is a private company.
What is the current stock price of Aitiologic?
Aitiologic is a private company, so its shares have no public market price. Caplight tracks Aitiologic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aitiologic worth (valuation)?
Valuation information for Aitiologic is not publicly available.
Can I buy Aitiologic stock?
Aitiologic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aitiologic's last funding round?
Aitiologic's most recent funding round was Seed on September 15, 2026.
Who are the main investors in Aitiologic?
Key investors in Aitiologic include PUSH VC, Ananda Ventures, Heal Capital.
Will Aitiologic IPO soon?
No public IPO plans have been announced for Aitiologic.
How can I track Aitiologic secondary market activity?
Caplight tracks bids, offers, and trades in Aitiologic's shares on secondary markets.